# Handoff — Empirical calibration and validation

## Current state

Specification, phased plan, test matrix, risks and ownership boundaries prepared
for review against Kairos `fae901558f07b7b717a676adbafbe2cdc78dea1c`.
This is a local CareOps coordination track extending upstream Track 21.
No Kairos implementation or upstream status/pin change is part of this delivery.

## Next implementation action

Review the spec and execute C0: refresh source/registry, resolve the scoped
ADR and contracts, then add the phase's tests. Respect all milestone entry gates.
All implementation checkboxes remain open through final milestone C6.

## Evidence to carry forward

Record source/lockfile/toolchain versions, commands actually executed, fixture
seeds, normalized input and output hashes, compatibility/performance results and
remaining limitations. Use the test matrix as the acceptance mapping. Planning
validation is documented in [the review record](../../planning-review.md).

## Release and synchronization

Update affected upstream owner plan/handoff and authoritative registry/phase
records after implementation evidence exists. Keep Kairos implementation commits
separate from the parent integration pin. Do not mark GPU, distributed, browser
or empirical clinical validation complete from CPU/synthetic evidence.

## C1.4 accepted synthetic ingestion phase — 2026-10-05

Reviewed integrated development pin `34e1d776e0ab4e2c84eb07f7c45779220df7e9b1` preserves accepted Q5.2 and the
90 exact tested C1 source files. Fresh native tests and C-01 runs, 666 independent
IPC/Parquet file reads, schema/units/nulls, negative controls and input/accepted/
excluded/censored count reconciliation pass. Final source has 48 successful
hosted checks and two documented conditional skips; phase, DAG, strict-clean and
evidence-boundary checks pass. See [C1.4 completion](../../evidence/c1.4-completion-20261005/README.md).
Historical failed attempts remain retained. C2, public API review, clinical
validation and release remain open. Earlier proposed/planning statements describe
their original delivery, superseded for C0/C1 only by recorded acceptance.

## C4.1 fixture preparation — 5 October 2026

Accepted source `6a17578a16d4bb13969961dfd116b3afaf7c8c6c`, evidence successor `a2cdeab33286e14db59f377449816702e79b2a6a`: 42 synthetic fixtures, eight native tests on Rust 1.99/1.88, ten Python tests, 23 pinned SciPy crosschecks and 28 independent exact numeric readbacks. Archive independently verified (137 members). Exact-head Linux/macOS native owner CI passed. [Evidence](../../evidence/c4.1-completion-20261005/README.md). Actual runtime candidate gate remains expected red; C4.2, C4.3, C4.4/C-04, clinical and release acceptance remain open.

## C4.2 private runtime qualification — 5 October 2026

Actual runtime source `59d7dbb0c004654e3da90951d42e2b983ef23993`; reviewed development head `21e48b257b5c89dd9756b647d9ee17f698f9496b` in Kairos draft PR221. All 42 frozen cases pass in Rust on 1.99/1.88 and an independent exact Python comparator. Full calibration: 119 pass/4 named ignores on each toolchain; strict current Clippy and formatting pass. False commit/toolchain and mutated metric fail as required. Exact-head Linux/macOS native owner CI and all 42 non-skipped child checks pass. Archive142 members independently read back. [Evidence and limits](../../evidence/c4.2-completion-20261005/README.md). Private API only; C4.3 Arrow, C4.4/C-04, clinical/release gates remain open. Historical C1/Q5/C4.1 records remain intact; parent publication is recorded separately.
